Acer Medical Unveils aiMed Ahead of IFA 2025, Showcasing the Future of AI in Healthcare

BERLIN (September 3, 2025) — Acer Medical, an Acer Group company specializing in medical imaging and AI-powered healthcare solutions, unveiled aiMed, its next-generation generative AI medical documentation system at the next@acer global press conference, ahead of IFA 2025 in Berlin. The milestone underscores Acer Medical’s expanding global footprint and its commitment to transforming healthcare through AI and digital innovation.

aiMed directly addresses one of the most pressing challenges in modern healthcare —clinical documentation overload. On average, healthcare providers spend up to 25% of their working hours [1] on medical record keeping, reducing valuable time for patient care and contributing significantly to burnout.

Leveraging advanced real-time AI processing tailored specifically for healthcare purposes, aiMed converts voice dictation or typed notes into structured electronic medical records (EMRs). This ensures accuracy, completeness, and compliance with healthcare documentation standards, while streamlining the clinical workflow.

By automating this task, aiMed enhances efficiency and helps:

  • Reduce the administrative workload for healthcare professionals
  • Minimize documentation errors in medical records
  • Maintain interoperability with hospital information systems (HIS / EMR platforms)
  • Enhance patient safety and quality of care by allowing more time for physician-patient interactions


Purpose-built for healthcare environments, aiMed’s ASR (Automatic Speech Recognition) function incorporates specialized medical terminology and contextual understanding. Its secure cloud-based architecture further ensures data protection.

Acer Medical also provides the VeriSee platform, an AI-assisted ophthalmology analysis platform. It can integrate multiple existing and new AI modules, allowing doctors to select and use them based on different clinical needs. The platform supports the following AI modules:

  • VeriSee DR: Diabetic Retinopathy
  • VeriSee AMD: Age-related Macular Degeneration
  • VeriSee GLC: Glaucoma Suspect


VeriSee analyzes color retinal images and delivers results within seconds. This allows hospitals and clinics to perform rapid and accurate screening, enabling timely interventions for high-risk patients and improving preventive care outcomes. The VeriSee solutions is now deployed in over 500 clinics and hospitals across 14 international markets.

Acer Medical is committed to driving innovation that enhances healthcare efficiency, reduces the burden on medical professionals, and improves patient outcomes worldwide. By combining generative AI for medical documentation with AI-powered screening tools, the company aims to redefine digital healthcare and accelerate the global adoption of smart, sustainable medical solutions.

 

 

About Acer Medical
Acer Medical is a subsidiary of the Acer Group focusing on artificial intelligence, dedicated to bridging the gap between technology and medicine through artificial intelligence, rich clinical data, and advanced software development, providing medical practitioners with actionable insights. Acer Medical operates a smart healthcare co-development platform to foster innovation. Leveraging deep learning and computer vision, it enhances diagnostic precision while supporting edge computing to ensure functionality even without internet access—improving usability in diverse clinical settings. Visit www.acer-medical.com for more information.

 

Press Contact: ​
Acer Corporate Communications (on behalf of Acer Medical)
press@acer.com

 

[1] A study on the relationship between nursing staff's working hours and job satisfaction https://doi.org/10.6615/HAR.201303.69.02

 

 

 

 

 

 

分享

最新故事

Website preview
宏碁智醫攜手臺灣國際合作發展基金會 以AI科技幫助中美洲友邦提升醫療品質
【2025年5月22日,台北訊】宏碁智醫(Acer Medical),近期再度拓展國際應用據點,其免散瞳自動眼底攝影機ARC-1000 與AI糖尿病視網膜病變輔助診斷軟體VeriSee DR,已正式導入中美洲友邦貝里斯( Belize) ,協助當地公立醫療體系專責眼科照護機構—貝里斯視障協會(Belize Council for the Visually Impaired, BCVI)- 提升糖尿病視網膜病變的早期篩檢能力。
acerhealthcare.prezly.com
Website preview
宏碁智醫與蔡司台灣簽署合作備忘錄(MOU)
攜手推動超廣角眼底攝影系統 AI 篩檢軟體驗證合作
acerhealthcare.prezly.com
Website preview
宏碁智醫攜手台中榮總 共同開發骨質密度異常篩檢軟體「智骨篩」 榮獲台灣新創獎
宏碁智醫(6857)與台中榮民總醫院(台中榮總)攜手合作,共同開發人工智慧骨質密度異常篩檢軟體「 智骨篩VeriOsteo OP」,榮獲由財團法人生技醫療科技政策研究中心頒發的「台灣新創獎」,該獎項為台灣生醫與大健康領域創新競逐的最高指標獎項,彰顯宏碁智醫在智慧醫療領域的指標性地位,以及在創新技術及產品對社會健康及產業發展的卓越貢獻。
acerhealthcare.prezly.com

在您的收件匣中取得更新

點擊「訂閱」,我確認我已詳閱並同意私隱政策